Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Tomasz Guszczyn; Monika Kulesza; Aleksandra Kicman; Joanna Motyka; Sławomir Ławicki

doi:10.12659/MSM.941523

18 December 2023: Clinical Research

Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Tomasz Guszczyn ^1ABDEF* , Monika Kulesza ^2BCDEF , Aleksandra Kicman ^3CF , Joanna Motyka ^2CF , Sławomir Ławicki ^2AEG

DOI: 10.12659/MSM.941523

Med Sci Monit 2023; 29:e941523

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 1 X-ray images belonging to the same patient: (A) healthy right knee; (B) left knee with separated bone fragment before PRP injection; (C) right knee after an observation period of 2 years; (D) left knee with separated bone fragment after PRP (Platelet-Rich Plasma) injection after observation period of 2 years.

Back to the Article

Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

Your Privacy